PBIGF Financials
Paradigm Biopharmaceuticals Limited - Financial statements & key metrics
Stock Price
$0.18
Market Cap
$81.32M
EPS
$-0.07
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$52120.00
Gross Profit
$-19892.00
Operating Income
$-22.89M
Net Income
$-18.77M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$24.57M
Total Liabilities
$3.39M
Shareholders Equity
$21.18M
Cash & Equivalents
$16.82M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-15.99M
CapEx
$5
Free Cash Flow
$-15.99M
Profitability Metrics
Gross Margin
24.5%
Operating Margin
-867.9%
ROE
-1.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PBIGF revenue?
PBIGF's most recent quarterly revenue was $52120.00. Annual revenue can be calculated by summing the four most recent quarters.
Is PBIGF profitable?
PBIGF reported a loss of $18.77M in the most recent quarter.
What is PBIGF market cap?
PBIGF has a market capitalization of $81.32M, making it a small-cap stock.
Does PBIGF have debt?
View PBIGF's balance sheet for debt information.
What is PBIGF cash flow?
PBIGF's most recent quarterly free cash flow was $-15.99M.